MIRA
INFORM REPORT
|
Report Date : |
26th February, 2007 |
IDENTIFICATION
DETAILS
|
Name : |
TAIWAN BIOTECH CO LTD |
|
|
|
|
Registered Office : |
22 Jie Shou Road Taoyuan City Taoyuan Hsien 330, Taiwan |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
09.10.1962 |
|
|
|
|
Com. Reg. No.: |
43211700 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Engaged in manufacturing & distributing several different lines of
pharmaceuticals for human & veterinarian use, nutritional supplements and
a variety of plastic & electronic medical devices. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD300,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
Company Name & Address
TAIWAN BIOTECH CO
LTD
22 JIE SHOU ROAD TAOYUAN CITY TAOYUAN HSIEN
330, TAIWAN
TEL :886-3-3612131
FAX :886-3-3670029
EXECUTIVE SUMMARY
INCORPORATION DATE :
OCTOBER 9, 1962
REGISTRATION NO. :
43211700
LEGAL FORM :
PRIVATE LIMITED COMPANY
CHIEF EXECUTIVE :
MR. YEN-HUI KO (CEO)
STAFF STRENGTH :
538
CAPITAL :
US$ 11,111,111
BUSINESS LINE :
MANUFACTURER
TURNOVER :
N/A (AS OF DEC. 31, 2005)
EQUITIES :
N/A (AS OF DEC. 31, 2005)
PAYMENT :
FAIRLY GOOD
RECOMM. CREDIT RANGE :
USD 300,000
MARKET CONDITION :
COMPETITIVE
FINANCIAL CONDITION :
STABLE
OPERATIONAL TREND :
STEADY
GENERAL REPUTATION :
AVERAGE
EXCHANGE RATE :
TWD 32.99025 = US$1 AS OF 2007-2-13
Adopted abbreviations:
ANS - amount not stated
NS - not stated
SC - subject company (the company inquired by you)
NA - not available
M - million
TWD –Taiwan New Dollars
*Company Name*
===============
Incorporated as : GLUCOSE CORP
Changed name to : SINTONG CHEMICAL INDUSTRIAL CO LTD
Year of change : 1962
Changed name to : TAIWAN BIOTECH CO LTD
Date of change : 7 February, 2002
*Company Registration*
====================
License number : 43211700
Date issued : 9 October, 1962
Issuing authority : Ministry of Economic Affairs (MOEA)
*Capital Details*
==============
Registered Capital as follows: NTD 35,000,000
Date Amount (NTD million)
-------
-----------------------------
1986 160
1987 200
1988 200
1989 200
1990 200
1992 300
*Corporate & Organization Structure*
=============================
Organization Chart
--------------------------
Chairman
|
Vice Chairman
|
President
|
Executive Vice President
|
|
|---------------------------------------|
New Product
Developing | Auditing Office
Committee |
|
|--------------------|-----------------|-----------|---------------|-----------|--------------|----------------|
Pharmaceuticals
Personnel | Administration Legal Finance MIS Trade
Research Institute Dept. | Affairs Dept. Center
Dept.
|
|
|
|------------------------------|-----------------|--------------|---------------------|
Animal Health
Pharmaceutical Plastic Pharmaceutical TDDS
Product Div. Business
Div. Product Production Div.
Div. Div.
*Company History*
===============
1979
- Procured 20ml BFS filler machine procured, marking the firm as a
premier local SVP (small volume parenteral) producer.
- Took the lead in Asia for introducing a Bottle Pack machine from
Rommelag Switzerland, offering an automatic production from PE blowing,
filling, and sealing to produce sterile parenteral agents including injection,
inhalation solution, eye care and ophthalmic
treatment solution which remained uncontested across Taiwan
1988
- Launched the first bio-equivalent test product in Taiwan, Ranidine,
formally certified by the Department of Health.
1989
- Procured another 20 ml BFS filling machine.
- Invested in TAIWAN BIOTECH CO LTD, offering upstream Actice
Pharmaceutical Ingrdients (API's).
1990
- Technical pact with the Japanese EISAI in jointly producing Amino-K
and rhe presentation of many of its related products.
- Joint development of transdermal delivery drug system (TDDS) with a
USA Pharmaceutical Development company.
1992
- Bestowed with a pilot new product R&D plan for transdermal
products sanctioned by the Ministry of Economic Affairs' Bureau of Industrial
Development.
1994
- CURIE CHEMICALS & PHARMACEUTICALS MFG CO LTD's plant joined TAIWAN
BIOTECH's production line in producing oral products.
- Procured another 20 ml BFS filler machine.
1995
- Launched innovative transdermal nicotine patch, Smokefree.
1996
- Launched AnPo, a labour inhibitors.
- Instilled a global trading enterprise development division in charge
of promoting export of house products.
1997
- Began export of a 20ml BFL (Blow Fill Seal) to Japan.
1998
- Made reinvestments at HUANENG PHARMACEUTICAL CO in mainland China.
- Formed dynamics venture capital in a moved to integrate the company's
venture investments.
1999
- Represented the US pharmaceutical company, Ocular Sciences' contact
lenses.
- Began sales and marketing of respiratory system medical equipment.
- Made investments to the US company, OPTICS CORP, through which TBC's
products started to export to the US.
2001
- Represented the US pharmaceutical company, Cephalon's Provigil - a
narcolepsy treatment solution.
- Implemented and surpassed the cGMP phase-one review.
2002
- Launched BIOTECH food manufactory at the Hsinchu Science-based
Industrial Park.
- Formed strategic alliance with FRESENIUS MEDICAL CARE CORP of Germany.
February 2005
- Bought FUJISAWA TAIWAN CO LTD's factory at Kuanyin Hsiang.
*Office & Facilities*
================
Size : 324,000 square feet
Location : Industrial area
Comments :
Serve as head office and factory 1.
Maintains over 20 licensed pharmacists and nutritionists.
Other Contact Details
------------------------------
Tel no :
2-23519839
Email address :
yvette@sintong.com/ jane@sintong.com/ wendy@mail.sintong.com
*Factories, Size & Locations*
========================
Maintains major manufacturing sites located in Taiwan.
- Parenteral plant
- BFS (Blow-Fill-Seal) parenteral plant
- Solid product manufacturing plant
- TDDS (Transdermal Drug Delivery System) plant
- Produces suspend release
patch, the nicotine patch that currently launched in the market.
Taoyuan Plant - The Active Pharmaceutical Ingredients plant
--------------------
- Injectable plant
- Antibiotics tablet plat
- Plastic medical product plant
- Transdermal patch plant
Activity : Produces antibiotics
Cephalosporin antibiotics and intermediate, noticeably of the Cephalexin that
has since been certified by the US Food & Drug Administration.
Hsinchu Plant
-------------------
- Medical device plant
Activity : Concentrates in the research and development
of health beneficial biotech foods and Chinese herbal medicine, noticeably of
the successful extraction of active substances derived from the American
Ginseng working with the Pharmaceutical Technology Centers that offers
beneficial yield for gastrointestinal and bodily health.
Tamshui Plant - Curie Plant
-------------------
- Tablet plant
Activity : Produces tablets,
capsules and oral solution and supports Taoyuan production plant in mapping out
a comprehensive product marketing portforlio.
Kuan Yin Plant
--------------------
- The newly acquired plant provides cephalosporin products in form of
tablets, capsules, and injections which support Taoyan main plant in mapping
out a comprehensive product portfolio. Also the new plant is fitting the world
trend of individual production site of antibiotics.
Veterans Pharmaceutical Plant
----------------------------------------
- Recently acquired the factory management authority, mainly supplies
gastrointestinal and respiratory treatment drugs, and skin improvement
products.
*Auditors*
=========
DIWAN, ERNST & YOUNG
*Industry Ranking*
================
Obtained the following ranks within Taiwan's manufacturing corporations.
Details of ranks are as follows:
Year Rank
------ --------
1985 742
1986 897
1987 947
1988 908
1989 830
1990 789
1992 675
Within the Pharmaceutical industry, the firm has held the following rank
:
Year Rank
------- --------
1986 11
1987 11
1988 11
1989 8
1990 9
*Sales Ranking*
============
Details of Ranks are as follows:
Year Rank
------ ------
1998 613
1997 675
*Insurance Companies*
==================
Insurance company : NAN SHAN LIFE INSURANCE CO LTD
CATHY INSURANCE CO LTD
Web
site: http://www.sintong.com/ The design is professional and the content
is well organized. At present it is both in Chinese and English version.
Email : trade-a@sintong.co
For the past two years there is no record of litigation.
Direct / Indirect Corporate Parent Details
Chairman : Mr. Chang-Chi
Kuo
Nationality : Taiwan
Direct Parent : TBS
LABORATORIES INC
Country : USA
*Major Shareholders*
=================
Shareholders'
Name No. of
shares
-------------------------- ------------------
Mr. Shou-hsiung Pai 13,401,076
Mr. Chin-piao Lin 13,401,076
Mr. Chang-Chi Ko 10,997,059
Mr. Shin-ming Hsu 10,997,059
Mr. Chun-hui Ko 7,280,510
Mr. Ming-teh Su 7,280,510
Mr. Chi-cheng Liao 3,547,086
Mr. Hsieh-chi Huang 2,906,738
Mr. Yen-Hui Ko 2,129,003
Mr. Hung-jen Yang 2,129,003
Mr. Shih-chien Huang 2,906,738
Mr. Kuo-jul Huang 363,859
Mr. Sheng-hsiung Hsu 128,669
Mr. Ming-ho Huang 0
Name Nationality Job Description Dept. / Division
Mr. Chang-Chi Ko Taiwanese
General Manager -
Mr. Fu-An Liu Taiwanese
Vice General Manager -
Mr. Hsien-Jen Liu Taiwanese
Vice General Manager -
Mr. Yen-Hui Ko Taiwanese
CEO -
Ms. Sindy Taiwanese Manager Human
Resources
*Main Products & Services*
======================
Specializes in manufacturing & distributing several different lines
of pharmaceuticals for human & veterinarian use, nutritional supplements
and a variety of plastic & electronic medical devices.
These pharmaceutical lines include :
- Transdermal therapeutic drugs
- Bulk pharmaceuticals
- OTC drugs & preparations
Also distributes variety of medical devices. These include :
- Single patient hemodialysis
units
- Hollow fiber dialyzers
- Syringe pump
- Infusion pump
- Hemodialysis concentrate
- Peritoneal solution
Core Products :
- Sustain release drugs Non-steroid anti-inflammatory agents
- Transdermal drug dosage Complete lines of contact lens solution
- Amino acid agents Unit dosage package of ophthalmic agents
- Cardiovascular agents Hemodialysis machines, solutions and supplies
- Antibiotic agents Veterinary healthcare products
- Super Generic Drugs (Bio-Equivalent products)
- Product Ingredient Dose
- Cefa (Cefamezin) Cefazolin 1g
- Cefadroxil (Duracef) Cefadroxil 500mg
- Cephalexin (Keflex) Cephalexin 500mg
- Cephazolin (Cefamezin) Cefazolin 500mg
- Ceporin (Capoten) Captopril 25mg
- Ceretal S.R. Tab (Trental) Pentoxifylline 400mg
- Cero (Keflor) Cefaclor 250mg
- Cinolone F.C. Tab (Cipro) Ciprofloxacin 250mg
- Cisa (Prepulsid) Cisapride 5mg
- Gem-s (Lopid) Gemfibrozil 600mg
- Lisacef (Velosef) Cephradine 250mg, 500mg
- Ranidine (Zantac) Ranitidine 150mg
- Sinflo (Tarivid) Ofloxacin 100mg, 200mg
- Sintec (Renitec) Enalapril Maleate 5mg, 20mg
- Smokfree Nicotine TDDS Nicotine 20.8mg, 31.2mg
- Arthritis drugs
- Osteoporosis drugs
- BPH treatment drugs
- Blood concentration & hypertension regulating drugs
- Control release drugs
- Dialysis treatment drugs
Products also
includes:
- Benzalkonium chloride
- captopril
- cefazolin sodium
- cephalexin monohydrate
- flumequine
- gemfibrozil
- lovastatin
- ofloxacin
- ranitidine
- spirulina powder
Products : Antibiotics
Dialysis
PE (polyethylene)
Antibiotics
Bulk drugs
Brand AnPo
Brand Ling Chih
Brand Sintong
Brand Smokefree
Brand TBC
*Competitors*
===========
The following locally based companies supply similar range of products:
- YUNG SHIN PHARMACEUTICAL INDUSTRY CO LTD
- ROCHE PRODUCTS LTD
- GIDDI PHARMA CO LTD
*Exhibition Participation*
====================
Participated in the following local exhibitions :
(1)
Exhibition fair : 9th
Taipei Int'l Food Show
Dates attended : 9-12 June, 199
Location :
Taipei World Trade Center - Exhibition Hall
(2)
Exhibition Fair :
The 4th Taiwan Int'l Biotech Exhibition 2003
Date attended : 24-27
July, 2003
Location :
Taipei World Trade Center
*Awards*
========
(1)
Award : Outstanding Biotech Awards
Awarded by : Ministry of
Economic Affairs (MOEA)
Year : 1992
Award : Outstanding Award
Awarded by : ROC Biotech Industry Development Council
Year : 1993
*Detailed Product Specifications*
==========================
Pharmaceutical
---------------------
(1) Metabolic Agents
- Amino Acid Agents
- Carbohydrate Agents
- Carbohydrate and Electrolyte
Agents
- Vitamin Preparations
- Water and Electrolyte Agents
- Water for Injection
(2) Circulation Agents
- Drugs for Atherosclerosis
- Intracranial Pressure Lowering Agents
- Cardiovascular Agents
- Anti-Hypertensive Agents
- Vasodilator
(3) Antimicrobial System Agents
- Anthelmintics
- Antibiotics
- Antimicrobial Agents
(4) Respiratory System Drugs
- Antitussives and Expectorants
- Bronchial Dilators
(5) Nervous System Drugs
- Anesthetics
- Anti-depression Agents
- Antihistamine Agents
- Non-Addictive Analgesics & Anti-inflammatory Drugs
- Preparations for Common Cold
- Smooth Muscle Relaxants
- Smooth Muscle Stimulants
- Tranquilizers
- Blood Agents
- Anticoagulants
- Plasma Substitute Agents
(6) Digestive System Drugs
- Antacids
- Anti-ulcer agents
- Hepatotonics
- Cholagogues
(7) Urogenital System Drugs
- Diuretics
- Hormones
- Urogenital Drugs
(8) External Agents
- Skin Agents
(9) Chinese herbal Product R&D
- Researching and developing methods including extraction, purification,
and formula development help bring
natural substances and Chinese herbal into the domain of health food and
drugs.
(10) Controlled release drugs
- A controlled release drugs have been developed to excel the quality of
drug dispensing.
(11) Sterile formulation
development
- Backed by professional know-how and the unique processing equipment
are adopted for leading sterile formulas research, produced by the automated PE
Blowing-filling-sealing.
(12) Dialysis treatment drugs
- Developing most comprehensive dialysis drugs of in ensemble for the local
market.
(13) Contact lens solution and ophthalmic drugs
- The unit dose package formula to improve the usage quality and easy to
use.
(14) Oral hygiene products
- The supplying of school children to prevent dental caries used in
mouthwash and related products
(15)
Health care products
- Health enhancing foods offer immunity enhancement and weight control,
and the nicotine patches that help smokers quit smoking.
Medical Device
--------------------
- Hemodialysis solution & powder
- Single-patient automatic dialysis Unit
- Hollow fiber dialyzer
- FL series
- BLF series
- Infusion pump & syringe pump
- Titanium mini-plating system
- Ultrasound bone densitometetry
- Aquaflex
Dental & Ophthalmic Care Products
------------------------------------------------
Main Products: 1 ml, 10 ml, 20 ml plastic ampoules; production capacity:
two to three hundred thousand ampoules per day
(1) For Injection
- Glucose: 5%, 20%, 50%
- Electrolyte:
0.9% Isotonic Sodium
Chloride
0.45% Sodium
Chloride
Potassium Chloride
15%
Lipolyte etc.,
Water for injection
(2) For Contact Lens Solution:
- Buffer Saline
- Fresh Tears
- Beautiful 3 in 1 Solution: Cleaning, Rinsing, Disinfecting Solution
for Soft lens
- H2O2 CARE SYSTEM: H2O2 (A), (B) Care System for Soft lens All-in-One
Solution for Soft Contact lens
(3) For Dental Use:
- Solution for mouth wash
(4) For Diluent
- Water: Injection grade
- Normal Saline 20 ml
Veterinary
--------------
(1) Animal health products
- Poultry
- Cephaxin soluble powder
- Trimeisu soluble powder
- Amocin soluble powder
- Tiamulin premix-10
- Sinmeisu soluble powder
- Gentacin soluble powder
- C. T. C. 15% soluble powder
- Koxiline soluble powder
- Swine
- Cephaxin soluble powder
- Trimeisu soluble powder
- Amocin soluble powder
- Tiamulin premix-10
- Gentacin soluble powder
- Lincofat
- Ji Ji Fa S.T. 250
- Ji Ji Fa S.T. 500
- O.T.C. premix-220
(2) CEPHAXIN Powder"S.T."
(3) Cephalosporin
- Cephaloglycin
- Cefadrxil
- Cephalexin
- Cefaclor
- Cephradine
- Cephapirin
- Cephalothin
- Cefazolin
- Cephaloridine
- Cefamandole
- Cefoxitin
- Cefotaxime
*Technologies Developed and/or Acquired*
===================================
Type of Technology : Transderminal drug delivery system
Acquired from : TBS LAS
Country : USA
*Quality Certification*
==================
API plant certified by the US Food & Drug Administration in 1994.
*Machinery & Equipment*
====================
Machine
Country of Origin Description
------------- -------------------------- ----------------
BFS filler machine -
Bottle pack machine Rommelag, Switzerland
High speed encapsulation machine Bosch, Germany Produce 150,000 capsules /hr Transdermal
drug delivery system
*Production Capacity*
==================
Current capacity : 78 BE
products
*Associations*
===========
Member of Taiwan Medical Industry Association
*Deal Making*
=============
Nature of deal :
Cooperative agreement
Parties Involved : EISAI
(JAPAN)
TBS
LABS (USA)
NIKKISO (JAPAN)
Details :
Signed a cooperative
agreement for product development
*Domestic Customers*
=================
Major local customers include:
- Medical treatment outlets
- Pharmacies
- Eyewear companies
- Convenient stores
*International Trade Ranking*
=======================
The firm has been ranked among Taiwan's Top Importers/Exporters based on
the standard measured by the Board of Foreign Trade (BOFT)
Details of rank are as follows :
Year Rank
----- ------
1997 3171
*IMPORTER AGENCY LISTING*
==========================
Supplier :
NIKKISO CO LTD
Country of Origin :
Japan
Product Description :
Hemodialysis machines
Brand :
Nikkiso
Year :
1987
*LOCAL BRANCHES & MANAGEMENT*
=================================
Branch :
TAIWAN BIOTECH CO LTD - CHANGHWA CITY
Branch Tel :
[+886] 4-7224347
Branch :
TAIWAN BIOTECH CO LTD - CHIAYI CITY
Branch Address : 76 Chi
Ming Rd Chiayi City, 600
Branch Tel :
[+886] 5-2758949
Branch Fax :
[+886] 5-2759060
Branch :
TAIWAN BIOTECH CO LTD - KAOHSIUNG CITY
Branch Address : Rm B
3Fl, 253 Ming Hua Rd Kushan Dist, Kaohsiung City, 804
Branch Tel :
[+886] 7-5550227
Branch Fax :
[+886] 7-5546890
Branch :
TAIWAN BIOTECH CO LTD - TAIPEI CITY
Branch Address : 5Fl,
10 Lin Sen South Rd Chungcheng Dist, Taipei City, 100
Branch Tel :
[+886] 2-23947581
Branch Fax :
[+886] 2-23519838
Branch :
TAIWAN BIOTECH CO LTD - TAICHUNG CITY
Branch Address : Rm B
8Fl, 238 Ta Ya Rd North Dist, Taichung City, 404
Branch Tel :
[+886] 4-22032703
Branch Fax :
[+886] 4-22032763
Branch :
TAIWAN BIOTECH CO LTD - YUNGKANG CITY
Branch Address : 8Fl-1, 349 Chung Hua Rd Yungkang
City, Tainan Hsien 710
Branch Tel :
[+886] 6-3125022
Branch Fax :
[+886] 6-3125150
Branch :
TAIWAN BIOTECH CO LTD - TAITUNG CITY
Branch Tel :
[+886] 8-8326319
Branch :
TAIWAN BIOTECH CO LTD - HUALIEN CITY
Branch Address : 124
Tzu Yu St Hualien City, Hualien Hsien 970
Branch Tel :
[+886] 38-326319
Branch Fax :
[+886] 38-341523
Branch :
TAIWAN BIOTECH CO LTD - TAOYUAN CITY
Branch Address : 445-2
Tao Ying Rd Taoyuan City, Taoyuan Hsien 330
Branch Fax :
[+886] 3-3777324
Branch :
TAIWAN BIOTECH CO LTD - HSINCHU CITY
Branch Address : 33
Tung 9th Rd Hsinchu City, 300
Branch Tel : [+886]
3-5789720
Branch Fax :
[+886] 3-5789733
Branch :
TAIWAN BIOTECH CO LTD (FACTORY 2)
Branch Address : 1 Kuo
Chien 1st Rd Kuanyin Hsiang, Taoyuan Hsien 328
*(Subsidiaries, Joint-ventures & Affiliates)
================================
Company Name : SINTONG
INFORMATION CO LTD
Address :
8Fl 10 Lin Sen S rd Chungcheng Dist Taipei City 100 Taiwan
Country :
Taiwan
Relationship :
Affiliate
Legal Form :
Private Limited Company
Company Type : Service
Industry :
Computer & Information Products
*Branches*
=========
Maintains (6) branches offices for sales & distribution in Northern,
Central, Southern & Eastern Taiwan.
PAYMENT
RATING : 3 OBTAINED SCORES :
74
|
Implication |
Implications |
|
|
1 |
Scores 85–100 |
Excellent |
|
2 |
Scores 75 – 84 |
Above Average |
|
3 |
Scores 50 – 74 |
Average |
|
4 |
Scores 35 – 49 |
Fair |
|
5 |
Scores 15 – 34 |
Below Average |
|
6 |
Scores 01 – 14 |
Poor |
|
NR |
No Data |
No Data |
The rating indicates the
payment pattern of SC based upon our Payment Database, comments from suppliers
of SC, information from banks (if available), as well as industrial sources.
Dealings on open terms may be possible for
MODERATE amounts depending on individual judgement experience.
*BANK DETAILS*
================
Bank Name : BANK OF TAIWAN
Branch :
Chungcheng Dist,Taipei City
Branch Address : 120
Chung Ching South Rd Section 1 Chungcheng Dist Taipei City 100 (Head
Office)
SWIFT Code :
BKTWTWTP
Bank Name :
INTERNATIONAL BANK OF TAIPEI (TAIPEI BUSINESS BANK)
Branch :
Chungshan Dist,Taipei City
Branch Address : Int'l
Bank of Taipei Bldg 36 Nanking East Rd Section 3 Chungshan Dist Taipei City 104
(Head Office)
SWIFT Code :
TPBBTWTP
*FINANCIALS SUMMARY (Currency: U.S. $'s)
=====================================
Year Sales Assets Net Income
1986 $13,555,555.56 $21,370,370.37 $354,444.44
1987 $13,925,925.93 $21,851,851.85 $129,629.63
1988 $16,037,037.04 $23,740,740.74 $100,000.00
1989 $18,629,629.63 $32,814,814.81 $1,810,370.37
1992 $30,148,148.15 $45,259,259.26 $1,530,740.74
1998 $52,925,925.93 $66,703,703.70 $5,000,000.00
2003 $42,598,068.05 $83,317,329.87 $1,186,995.39
2004 $47,789,473.68 $82,586,466.17 $2,255,639.10
2005 $52,764,707.74 $97,703,033.18 $981,516.59
*Int´l Trade Activity (Currency:
U.S. $'s)
===============================
Year Imports Exports Total
1986 $1,100,000.00 $0.00 $1,100,000.00
1987 $1,600,000.00 $0.00 $1,600,000.00
1988 $2,100,000.00 $0.00 $2,100,000.00
1989 $2,500,000.00 $0.00 $2,500,000.00
1996 $5,000,000.00 $0.00 $5,000,000.00
1997 $6,300,000.00 $100,000.00 $6,400,000.00
1998 $6,400,000.00 $900,000.00 $7,300,000.00
2000 $9,224,433.00 $1,108,149.00 $10,332,582.00
2001 $7,061,803.00 $1,014,740.00 $8,076,543.00
2002 $5,741,073.00 $1,298,188.00 $7,039,261.00
*Financial Ratios*
================
Year Net Worth Return in Return on
Debt to Return
on
(NT$ Million) Sales (%) Networth (%)
Equity (%) Asset (%)
--------
------------------- -------------- ------------------ --------------- --------------
1986 127.67 2.61 5.92 352.45
1987 165.54 0.93 2.43 256.81
1988 168.24 0.62 1.61 281.53
1989 216.25 9.70 25.42 310.06
1990 218.81 1.49 3.94 293.88
1992 573.66 5.07 9.28 113.08
1998 608.00 9.45 22.00 66.24 7.50
SC is considered an old-established business in large size.
It is considered a credit line up to USD300,000 appears to be within SC’s
capacities.
ATTACHED: TRADE REFERENCES
SIC PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Manufacturing 2833 Medicinal
and botanicals
Manufacturing 2834 Pharmaceutical
preparations
Manufacturing 2844 Toilet
preparations
Manufacturing 2899 Chemical
preparations
Manufacturing 3841 Surgical
and medical instruments and apparatus
Manufacturing 3842 Orthopedic,
prosthetic, and surgical appliances and supplies,
Trading 2800 Chemicals
and Allied Products
Trading 2899 Chemical
preparations
Trading 5047 Medical/Dental
Equip/Supplies
HARMONIZED PRODUCT CLASSIFICATION & ACTIVITY
Activity Code Product/Service Description
Manufacturing 1108200000 Insulin
Manufacturing 1211908030 Substances
having anesthetic, prophylactic or therapeutic properties and
principally
used as medicaments or ingredients thereof, fresh or dried
Manufacturing 1302194020 Ginseng,
crude
Manufacturing 1519110000 Stearic
acid
Manufacturing 2936 Provitamins
and vitamins & derivatives & intermixs
Manufacturing 2936295020 Vitamins
d and their derivatives
Manufacturing 3000 Pharmaceutical
products
Manufacturing 3003 Medicaments
of mixtures, not dosage etc form
Manufacturing 3004 Medicaments,
mixed or not, in dosage etc form
Manufacturing 3004105010 Medicaments
containing penicillins or derivatives thereof(excluding penicillin g
salts),
or streptomycins or their deriv, for veterinary use
DETAILED PRODUCT CLASSIFICATION & ACTIVITY
Activity Product/Service
Description
Manufacturing Cephalexin
Manufacturing Cephalosporins
Manufacturing Chinese herbal medicines
Manufacturing Contact lens solutions
Manufacturing Digestive drugs
Manufacturing Opthalmic pharmaceuticals
Manufacturing Opthalmic equipment
Manufacturing Natural health foods
Manufacturing Medical x-ray apparatuses
Manufacturing Medical equipment
INTERNATIONAL TRADE : ACTIVITY & MARKETS
Exporting to Asia
Exporting to Cambodia
Exporting to China
Exporting to Europe
Exporting to Hong Kong
Exporting to Japan
Exporting to North America
Exporting to Pakistan
Exporting to Philippines
Exporting to Singapore
Exporting to USA
Exporting to Vietnam
Importing from Asia
Importing from Europe
Importing from Japan
Importing from USA
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
PRIVATE & CONFIDENTIAL : This information
is provided to you at your request, you having employed MIPL for such purpose.
You will use the information as aid only in determining the propriety of giving
credit and generally as an aid to your business and for no other purpose. You
will hold the information in strict confidence, and shall not reveal it or make
it known to the subject persons, firms or corporations or to any other. MIPL
does not warrant the correctness of the information as you hold it free of any
liability whatsoever. You will be liable to and indemnify MIPL for any loss,
damage or expense, occasioned by your breach or non observance of any one, or
more of these conditions